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INTRODUCTION
The bronchial epithelium has traditionally been recognized as 
a physical barrier protecting the host from its environment. How-
ever, epithelial cells play a central role in the regulation of airway 
immunity, affecting inflammation and host defenses in diseas-
es of the airway. Epithelial cells release a wide range of proin-
flammatory mediators and multifunctional cytokines in re-
sponse to exposure to inhaled environmental factors or micro-
organisms. The precise mechanisms are not fully understood, 
but epithelial cells are thought to play a major part in the regu-
lation of host inflammatory status as well as airway structure 
and function.1,2
Lipid rafts are subdomains of the epithelial cell membrane that 
contain high concentrations of cholesterol and glycosphingo-
lipids. They interact with one another and pack tightly together 
to form cell membrane structures. Thus, lipid rafts provide a 
platform for multiple signaling pathways and act as key modu-
lators of certain disease pathways.3 Lipid entities render lipid 
rafts insoluble in nonionic detergents and cause them to sepa-
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rate from their surroundings. Cholesterol, the most abundant 
lipid component of animal cell membranes, regulates mem-
brane fluidity and plays a crucial role in the formation and sta-
bilization of membrane microdomains. It is also an important 
contributor to cell-cell adhesion, migration, and even endocy-
tosis.4-7 However, despite increasing interest in the bronchial 
epithelium, the possible role of cholesterol in inflammation of 
the airway or the development of asthma has not been investi-
gated.
Among the numerous cytokines and chemokines released 
from human airways, interleukin-8 (IL-8) is a representative 
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Purpose: The lipid entities of cell membranes are components of the immune system and important mediators of inflammation. Despite increasing 
interest in the function of epithelial cells in inflammation, the role of cholesterol in this process has not been described. Here, we investigated the 
effect of cholesterol depletion on the inflammatory process in airway epithelial cells via the expression of interleukin (IL)-8 as a marker of inflamma-
tion. Methods: A 549 cells were treated with 0.5% methyl-β-cyclodextrin as a selective cholesterol extractor. The IL-8 level was assessed by en-
zyme-linked immunosorbent assay and reassessed after cholesterol repletion. Mitogen-activated protein kinase (MAPK) inhibitors were used to de-
termine the upstream signaling pathway for IL-8 production in cholesterol-depleted cells. Results: We found a relationship between the amount 
of cholesterol in A 549 cells and inflammation of the airway. IL-8 production was increased in cholesterol-depleted A 549 cells and restored by cho-
lesterol repletion. IL-8 production was decreased by pretreatment with the extracellular signal-regulated kinase (ERK) inhibitor U0126 but not with 
JNK inhibitor II or the p38 MAPK inhibitor SB202190. Conclusions: Our findings suggest that inflammatory responses are increased in cholester-
ol-depleted epithelial cells via the MAPK signaling system, predominantly by the ERK pathway. We conclude that the lipid components of airwayep-
ithelial cells may play a role in the inflammatory process.
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chemokine expressed by bronchial epithelial cells. IL-8 medi-
ates cell migration during inflammation of the airway.8,9 In ad-
dition, patients with severe asthma have increased levels of IL-8 
in their BAL fluids. In addition, various stimuli, including house 
dust mites, cockroaches, and microbes, induce IL-8 production 
in bronchial epithelial cells and promote inflammation.10-13
Here, we investigated the effect of cholesterol depletion in air-
way epithelial cells on the production of IL-8 and its association 
with inflammation of the airway. 
MATERIALS AND METHODS 
Cell culture
The human epithelial-like lung carcinoma cell line A 549 was 
obtained from the American Type Culture Collection (Manas-
sas, VA, USA). Cells were cultured in F12K medium (Sigma, St. 
Louis, MO, USA) supplemented with 10% fetal bovine serum 
containing 100 U/mL penicillin and streptomycin (GibcoBRL, 
Grand Island, NY, USA). At all stages of culture, the cells were 
maintained in an incubator at 37°C with 5% CO2.
Cholesterol depletion and repletion
Methyl-β-cyclodextrin (MβCD; Sigma) binds specifically to 
cholesterol to disturb the association of proteins with lipid rafts.14 
It is therefore presumed to change the structure and function of 
the cell membrane by disrupting lipid rafts.15-17 A stock solution 
of 10% MβCD in phosphate-buffered saline (PBS) was stored at 
4°C. This solution was used at concentrations of 0.5, 1, and 2% 
(v/v). After serum starvation for 24 h, cells were incubated with 
the indicated concentrations of MβCD for 1 h at 37°C for cho-
lesterol depletion. The culture medium was replaced with fresh 
serum-starved medium at the indicated times, and the cells were 
maintained at 37°C in an incubator with 5% CO2. For cholester-
ol repletion, MβCD-treated cells were incubated for 1 h in the 
presence of 70 μg/mL cholesterol and 0.2% MβCD. The cells 
were then further incubated in fresh serum-free medium in an 
incubator. 
Cell viability 
A 549 cell viability at various concentrations of MβCD was 
measured with a Cell Counting Kit-8 (Dojindo, Kumamoto, Ja-
pan). The day before the experiment, 100 μL cells were seeded 
into 96-well microplates at a density of 1×104 cells per well. Af-
ter 24 h of incubation, 10 μL cells per well were treated with var-
ious concentrations of MβCD for 1 h, followed by incubation 
with an additional 10 μL Cell Counting Kit-8 solution for 1 h. The 
absorbance was then measured at 450 nm with an enzyme-linked 
immunosorbent assay (ELISA) reader; the compensated absor-
bance was 590 nm.
Lipid extraction and cholesterol assay
A 549 cells pretreated with MβCD to deplete cholesterol were 
washed in cold PBS buffer and extracted with Folch solution 
containing chloroform and methanol at a 2:1 ratio. The choles-
terol released by the Folch method was solubilized in the organ-
ic phase, and the amount of cholesterol was measured with a 
cholesterol probe following vaporization of the organic phase. 
The organic phase was dried under a speed vacuum (Savant In-
struments Inc., New York, NY, USA) for 30 min, then solubilized 
with 2-propanol and 10% Triton X-100. Membrane cholesterol 
was assayed using a Cholesterol/Cholesteryl Ester Quantitation 
Kit (Calbiochem-Novabiochem, La Jolla, CA, USA), according 
to the manufacturer’s instructions, Samples and standards were 
loaded and reacted by the addition of a reaction mixture con-
taining cholesterol buffer, probe, and enzyme without light for 
1 h. The absorbance at 570 nm was measured with an ELISA 
reader; the compensated absorbance was 590 nm. A BCA Pro-
tein Assay Kit (Pierce, Rockford, IL, USA) was used to quantify 
the extracted proteins, which were collected with Mammalian 
Protein Extraction Reagent (Pierce) and normalized to the vol-
ume. 
Measurement of human IL-8 and MAP kinase (MAPK) assay 
After treatment with 0.5% MβCD for 1 h, cells were treated with 
fresh serum-free medium and incubated for 2, 5, 10, and 24 h at 
37°C. They were then stored at -70°C until they were assayed. 
The IL-8 levels in the culture supernatants were determined us-
ing a specific ELISA against human IL-8 (R&D Systems, Minne-
apolis, MN, USA) according to the manufacturer’s instructions. 
To investigate the effect of changes in transcription factor activ-
ity on IL-8 expression in human lung epithelial cells, the selec-
tive MAP/extracellular signal-regulated kinase (ERK) [MEK] in-
hibitor PD98059 or U0126, c-JUN NH2-terminal kinase (JNK) 
inhibitor JNK II Inhibitor, or p38 MAPK inhibitor SB203580 or 
SB202190 (Calbiochem-Novabiochem) was added 1 h before 
stimulation with MβCD and was present throughout the incu-
bation period. 
RNA preparation and real-time polymerase chain reaction 
(PCR) 
Reverse transcription-PCR (RT-PCR) was used to examine the 
mRNA expression of IL-6, IL-8, and TNF-α. Total RNA was iso-
lated from cells using Trizol reagent (Invitrogen, Carlsbad, CA, 
USA) prior to cDNA synthesis. PCR amplification was carried 
out using specific primer pairs. The primer sequences used were 
obtained from Primer Bank (http://pga.mgh.harvard.edu/prim-
erbank). Fold changes were calculated using the comparative 
ΔΔCt method. The gene encoding glyceraldehyde-3-phosphate 
dehydrogenase (GADPH) was analyzed as an internal control 
in each sample. 
Western blot analysis 
MβCD-treated cells were lysed with lysis buffer (50 mM HEPES, 
pH 7.5; 150 mM NaCl; 1 mM EDTA; 10% glycerol; and 0.5% NP-
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40). Protein samples were mixed with 5× SDS-PAGE buffer con-
taining β-mercaptoethanol and heated at 95°C for 5 min. Whole-
cell lysates (30 μg) were separated by 10% SDS-PAGE, then elec-
trotransferred to nitrocellulose membranes (GE Healthcare, 
Stockholm, Sweden). The membranes were blocked for 1 h with 
5% skim milk in TBST buffer (10 mM Tris-HCl, pH 7.5; 150 mM 
NaCl; and 0.2% Tween 20), then washed three times with TBST 
at room temperature. The blots were incubated overnight with 
specific antibodies (1:1,000) in 5% skim milk in TBST buffer at 
4°C. After incubation with secondary antibodies (1:2,000), the 
signal was detected using the ECL Plus (GE Healthcare) and CL-
XPosureTM film (Thermo Scientific, Waltham, MA, USA) or an 
ImageQuantTM LAS 4,000 Mini Biomolecular Imager (GE Health-
care). 
Statistical analysis 
All data are expressed as the mean±SEM of at least 3 individ-
ual experiments. A statistical analysis comparing the treatment 
and control groups was carried out using Student’s t-test. 
P<0.05 was considered significant.
RESULTS
Induction of cholesterol depletion by MβCD in A 549 cells
We estimated the amount of cholesterol in the growth media 
of control and MβCD-treated cultures. After treatment with 0.5, 
1, or 2% MβCD for 1 h at 37°C, the cells showed a decreased 
amount of cholesterol (3.15±0.52, 4.73±0.75, and 4.17±0.68 
μg/mL, respectively) compared to untreated cells (8.22±0.11 
μg/mL). However, there was no significant difference in the 
amount of cholesterol among the MβCD-treated groups. In ad-
dition, the amount of cholesterol in the cell was at its lowest fol-
lowing treatment with 0.5% MβCD, showing an approximately 
60% decrease compared to the control (Fig. 1). Subsequent ex-
periments were thus carried out using epithelial cells treated 
with 0.5% MβCD. 
Alteration of cell viability by MβCD
To determine whether cholesterol depletion by MβCD had 
any effect on cell viability, we compared the untreated cells to 
the A 549 cell cultures treated with 0.5, 1, or 2% of MβCD for 1 h. 
There were no dramatic changes in overall cell viability com-
pared to the control (96.8, 95.3, and 94.2%, respectively, Fig. 2) 
but statistical differences showed in 1 and 2% of MβCD-treated 
cells. We concluded that 0.5% MβCD should be used in our 
subsequent experiments.
Effect of cholesterol depletion on human IL-8 production 
The effect of cholesterol depletion on IL-8 production was ex-
amined in airway epithelial cells treated with 0.5% MβCD. Cho-
lesterol-depleted cells produced more IL-8 than control cells 
at different time points (2, 5, 10, and 24 h). IL-8 production in-
creased in a time-dependent manner, with maximum produc-
tion at 24 h. Cells treated with 0.5% MβCD produced 300.4±7.9 
pg/mL at 2 h, 477.7±1.5 pg/mL at 5 h, 816.7±55.2 pg/mL at 10 
h, and 867.6±38.9 pg/mL at 24 h compared to 40.8±2.3 pg/mL 
at 2 h, 80.4±0.2 pg/mL at 5 h, 158.2±8.3 pg/mL at 10 h, and 
244.6±6.0 pg/mL at 24 h for control cells. We verified that the 
IL-8 level decreased after treatment with both 0.5% MβCD and 
70 μg/mL cholesterol, similar to in the control cells (Fig. 3A). 
When tested by RT-PCR with GAPDH as an internal control, the 
A 549 cells depleted of cholesterol with 0.5% MβCD showed 
greater IL-8 mRNA expression. IL-8 expression peaked at 2 h 
and returned to baseline 24 h after MβCD stimulation (Fig. 3B). 
Role of MAPK signaling in IL-8 production
To investigate the link between IL-8 production in cholester-
ol-depleted cells and the MAPK signaling pathway, which is in-
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Fig. 1. Determination of the cholesterol level in untreated and MβCD-treated A 
549 cells. The amount of cholesterol in the cell decreased after MβCD treatment. 
Each bar represents the mean±SEM of 3 independent experiments. Cholester-
ol in the cell was at its lowest level following treatment with 0.5% MβCD. 
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Fig. 2. Cholesterol depletion by 0.5% MβCD does not significantly change A 
549 cell viability. A 549 cells preincubated with the indicated concentrations of 
0.5% MβCD for 1 h did not show any significant change in viability compared 
to control cells. The data are expressed as the mean±SEM showing 96.8, 95.3, 
and 94.2% cell viability. *P<0.05 vs. the control alone. 
Cholesterol Depletion in Airway Epithelial Cells
Allergy Asthma Immunol Res. 2013 November;5(6):402-408. http://dx.doi.org/10.4168/aair.2013.5.6.402
AAIR 
405http://e-aair.org
volved in airway inflammatory diseases, we examined the ef-
fect of MAPK inhibitors on IL-8 production. IL-8 production 
was decreased by pretreatment with the ERK inhibitor U0126 
(50 μM), but JNK inhibitor II (100 μM) and the p38 MAPK in-
hibitor SB202190 (50 μM) did not significantly reduce IL-8 pro-
duction (Fig. 4A). The level of IL-8 was decreased by almost 80% 
by U0126 but by only 10.9 and 31.4% by JNK inhibitor II and 
SB202190, respectively, compared to MβCD treatment alone. 
To demonstrate the intracellular activation of MAPK signaling, 
we examined the phosphorylation of ERK, p38 MAPK, and JNK 
in MβCD-treated cells from 0 to 60 min. As shown in Fig. 4B, we 
detected small amounts of phosphorylated ERK 1/2 MAPK in 
untreated A 549 cells, whereas treatment with MβCD induced 
ERK 1/2 MAPK phosphorylation. ERK 1/2 MAPK activation was 
maximized at 30 min, but neither p38 MAPK nor JNK activation 
was detected. 
Effect of cholesterol depletion on the production of other 
cytokines 
To identify the effect of cholesterol depletion on inflammato-
ry responses in the airway, we examined the production of oth-
er cytokines released from A 549 cells. When tested by RT-PCR 
with GAPDH as an internal control, cholesterol depletion by 
MβCD resulted in elevated IL-6 and TNF-α mRNA expression 
in the A 549 cells. IL-6 and TNF-α expression peaked 2 h after 
MβCD stimulation (Fig. 5A and B). 
DISCUSSION
The epithelium, which represents the first contact surface with 
the external environment, forms a tight and impermeable bar-
rier for the maintenance of tissue homeostasis under normal 
circumstances.1 The structural integrity of the epithelium is also 
Fig. 3. Effects of cholesterol depletion on IL-8 production in airway epithelial cells. (A) A 549 cells were treated with 0.5% MβCD and the supernatants were assessed 
by ELISA after 2, 5, 10, and 24 h. IL-8 production was increased in cholesterol-depleted cells and recovered after cholesterol repletion. (B) The induction of IL-8 mRNA 
expression in human respiratory epithelial cells. Total RNA was isolated and reverse-transcribed, and the resulting cDNA was amplified by real-time PCR. Cells stim-
ulated with 0.5% MβCD showed enhanced IL-8 mRNA expression. *P<0.05 vs. the control. 
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Fig. 4. Effects of pretreatment with MAPK inhibitors on MβCD-induced IL-8 production. (A) IL-8 production was decreased by pretreatment with the ERK inhibitor 
U0126 (50 μM) but not by JNK inhibitor II (100 μM) or the p38 MAPK inhibitor SB202190 (50 μM). **P<0.01 vs. MβCD-treated cells. (B) Phosphorylation assays of 
MAPK activity. Cells treated with MβCD were harvested at the indicated time points and then lysed. Equal amounts of the cell extracts were resolved on 10% acryl-
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maintained through cell-cell and cell-extracellular matrix inter-
actions. However, air pollutants or infectious particles can in-
crease the permeability of the epithelium and penetrate the air-
way, inducing epithelial cell damage or death. Allergens such 
as house dust mites and pollen can also disrupt the integrity of 
the mucosa through the direct extracellular cleavage of tight 
junctions.2 Such allergens also enhance inflammatory pathways 
that make the epithelium interact with other cells.18,19 In addi-
tion, epithelial cells can recruit and modulate immune cells to 
cause persistent inflammation through adhesive interactions, 
selective cytokine release, and cell-specific receptor expression. 
Thus, epithelial cells can modulate the structure and function 
of the airway by contributing to host defenses and innate im-
munity.1,2
A recent innovation in our understanding of the role of epi-
thelial cells in inflammation of the airway has to do with the in-
fluence of impaired innate immunity and epithelial cell injury 
on the progression of inflammation, especially in the case of 
asthma.18-20 The airway epithelium in asthma patients is dam-
aged, with the disruption of tight junctions accompanied by a 
loss of junctional proteins in response to environmental factors 
such as dust mite allergens, fungal allergens, viral infections, 
and smoke.21,22 The damaged epithelium results in barrier dys-
function, epithelial fragility, and abnormal repair responses in 
the asthmatic airway, creating a condition that is similar to in-
flammatory conditions of the skin such as atopic dermatitis or 
those of the gut in the case of food allergy.18,19 Many studies have 
focused on compromised tight junctions and epithelial cell 
protein complexes to determine the relationship between asth-
ma and the airway epithelium.18-22 However, the role of lipid 
components of the epithelial cell membrane in inflammation 
of the airway has not been comprehensively studied. 
Lipid rafts are dynamic nanoscale membrane microdomains 
that contain large amounts of cholesterol and sphingolipids in-
volved in signaling platforms.3 Cholesterol, an essential compo-
nent of the plasma membrane, has been implicated in the reg-
ulation of membrane fluidity, permeability, and cell surface re-
ceptor function.4-6 Because cholesterol contributes to the estab-
lishment of a cornified barrier, it plays a crucial role in keratino-
cytes. Atopic dermatitis has even been shown to occur in paral-
lel with keratinocytes disrupted by lipid rafts.17 We hypothesize 
that inflammatory diseases of the airway are influenced by air-
way epithelial cells with disrupted lipid rafts, similar to kerati-
nocytes in atopic dermatitis. 
To clarify the relationship between cholesterol and inflamma-
tion of the airway, we used MβCD to damage lipid rafts in airway 
epithelial cells. We identified a concentration of MβCD capable 
of inducing significant changes in cholesterol levels in the cell. 
We then demonstrated that the amount of cholesterol in the cell 
was significantly decreased after incubation with 0.5% MβCD, 
without effect on cell viability. 
IL-8 is a major chemokine of the CXC chemokine subfamily 
that acts as a chemoattractant for neutrophils released from the 
bronchial epithelium.8 IL-8 plays a key role in triggering and 
perpetuating inflammation in patients with severe asthma. In 
addition, the expression and release of IL-8 increase in response 
to other stimuli such as allergens and infectious particles.10-13 
Hence, we used IL-8 as an inflammatory marker in this study, 
and IL-8 production rose in cholesterol-depleted epithelial 
cells. Based on these results, we recognize that IL-8 production 
in human respiratory epithelial cells could be affected by the 
cholesterol content in the membrane through the depletion of 
cholesterol in the cell in the absence of any other allergen.
MAPK regulates IL-8 expression and release in response to 
various allergens and viruses in airway epithelial cells, resulting 
in an influence on cell signaling pathways in diseases of the air-
way. Among ERK, JNK, and p38 MAPK, ERK-regulated IL-8 
production has been suggested as a distinct signaling process 
in chronic diseases of the airway.10-13 We investigated the effect 
of MAPK inhibitors on IL-8 production using U0126, JNK inhib-
Fig. 5. Effect of cholesterol depletion on IL-6 and TNF-α mRNA expression. (A) A 549 cells were treated with 0.5% MβCD and/or 70 μg/mL cholesterol for the indicat-
ed time. Total RNA was isolated and reverse-transcribed, and the resulting cDNA was amplified by real-time PCR. The cholesterol-depleted cells showed enhanced 
proinflammatory cytokine release. The mRNA expression of IL-6 (A) and TNF-α (B) increased and peaked at 2 h following MβCD treatment. *P<0.05 vs. the control. 
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itor II, and SB202190 and sought to determine whether IL-8 
production in cholesterol-depleted cells was affected by the 
MAPK signaling pathway. Our results suggest that activation of 
the ERK pathway is a relatively strong contributor to IL-8 pro-
duction in cholesterol-depleted cells, in agreement with previ-
ous studies of allergen-induced inflammation of the airway.10-13
In addition, we investigated the expression of other cytokines 
generated by airway epithelial cells. IL-6 can stimulate T cells 
and contribute to the development of Th2-mediated inflamma-
tion. It was previously demonstrated that epithelial IL-6 expres-
sion increased after exposure to fungi, house dust mites, or com-
mon respiratory viruses.1 In addition, airway epithelial cells pro-
duce pleiotropic cytokines, including TNF-α, which plays an im-
portant role in severe refractory asthma. Targeting TNF-α may 
be a novel therapeutic approach to treating asthma.23 We found 
that the mRNA expression of IL-6 and TNF-α was increased in 
cholesterol-depleted epithelial cells. Cholesterol depletion in 
the airway epithelium may be related to inflammatory respons-
es through the production of several inflammatory products. 
Genome expression profiling has been performed in choles-
terol-depleted keratinocytes from patients with atopic dermati-
tis.17 What is interesting is that patients with genetic differences 
tend to be susceptible to both this condition and other related 
allergic diseases.24,25 Such large-scale genome profiling and ge-
netic experiments have confirmed that the disruption of lipid 
rafts can lead to inflammatory disease under certain circum-
stances. 
In conclusion, our findings suggest that the disruption of lipid 
rafts plays an important role in inflammation of the airway. 
Bronchial epithelial cells with cholesterol depletion released a 
large amount of IL-8, and IL-8 production was regulated by the 
MAPK signaling pathway, predominantly through ERK. In ad-
dition, cholesterol depletion in airway epithelial cells induced 
the elevation of other proinflammatory cytokines generated by 
the airway epithelium. Considering that the bronchial epitheli-
um may be a novel target for new therapies for inflammatory 
diseases of the airway, additional studies of cholesterol and lip-
id rafts in human airway epithelial cells are needed.
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